BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26484677)

  • 1. Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
    Gu Y; Lei D; Qin X; Chen P; Zou YM; Hu Y
    PLoS One; 2015; 10(10):e0140862. PubMed ID: 26484677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers.
    Osipov ID; Zaporozhchenko IA; Bondar AA; Zaripov MM; Voytsitskiy VE; Vlassov VV; Laktionov PP; Morozkin ES
    Adv Exp Med Biol; 2016; 924():9-12. PubMed ID: 27753010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.
    Hart M; Nolte E; Wach S; Szczyrba J; Taubert H; Rau TT; Hartmann A; Grässer FA; Wullich B
    Mol Cancer Res; 2014 Feb; 12(2):250-63. PubMed ID: 24337069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
    Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
    J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
    Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
    Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
    Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
    Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer.
    Zedan AH; Hansen TF; Assenholt J; Pleckaitis M; Madsen JS; Osther PJS
    Tumour Biol; 2018 May; 40(5):1010428318775864. PubMed ID: 29775158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
    Wach S; Nolte E; Szczyrba J; Stöhr R; Hartmann A; Ørntoft T; Dyrskjøt L; Eltze E; Wieland W; Keck B; Ekici AB; Grässer F; Wullich B
    Int J Cancer; 2012 Feb; 130(3):611-21. PubMed ID: 21400514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
    Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M
    BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study.
    Alshalalfa M; Bader GD; Goldenberg A; Morris Q; Alhajj R
    BMC Syst Biol; 2012 Aug; 6():112. PubMed ID: 22929553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
    Casanova-Salas I; Rubio-Briones J; Calatrava A; Mancarella C; Masiá E; Casanova J; Fernández-Serra A; Rubio L; Ramírez-Backhaus M; Armiñán A; Domínguez-Escrig J; Martínez F; García-Casado Z; Scotlandi K; Vicent MJ; López-Guerrero JA
    J Urol; 2014 Jul; 192(1):252-9. PubMed ID: 24518785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
    Sun Y; Jia X; Hou L; Liu X
    Urology; 2016 Aug; 94():313.e1-6. PubMed ID: 27179774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
    Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
    PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.